Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemcitabine with or without adjuvant chemoradiation after pancreaticoduodenectomy for pancreatic head cancer
2005-000933-39Phase 2Completed
- Sponsor
- European Organisation for Research and Treatment of Cancer
- Start
- Apr 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of gemcitabine in pancreatic adenocarcinoma (PDAC) (2 arms), sponsored by European Organisation for Research and Treatment of Cancer. Started Apr 2005; status: completed.
02
Drugs
gemcitabine
03
Conditions
pancreatic adenocarcinoma (PDAC)
Beyond the preview
Go deeper on 2005-000933-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-000933-39.